Search research articles
Contact Us
Filters
Showing results (121-130 of 248) with videos related to
Page
of 25
Sort By:
Psychiatry Investigation
|
November 29, 2022
The Effect of Temperament on the Association Between Pre-treatment Anxiety and Chemotherapy-Related Symptoms in Patients With Breast Cancer
Jung-In Choi, Sanghyup Jung, Gyu Han Oh, et al.
Frontiers in Immunology
|
December 5, 2022
Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer
Jinyong Kim, Jiyun Jeong, Chan Mi Lee, et al.
Cancers
|
February 8, 2020
TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy
Jin Won Kim, Ahrum Min, Seock-Ah Im, et al.
BMC Cancer
|
July 9, 2016
Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer
Eun-Shin Lee, Wonshik Han, Min Kyoon Kim, et al.
Gut and Liver
|
May 19, 2010
Acute pancreatitis complicating spontaneous acute exacerbation of chronic hepatitis B virus infection: case report and review of the literature
Kyo-Sang Yoo, Kyung-Hun Lee, Kyung Rim Huh, et al.
Breast (Edinburgh, Scotland)
|
March 24, 2026
Impact of trastuzumab deruxtecan (T-DXd) and brain stereotactic radiosurgery on intracranial control and radionecrosis risk in HER2-positive or -low breast cancer brain metastases
Seok-Joo Chun, Kyubo Kim, Won Ick Chang, et al.
Cancer Research and Treatment
|
August 8, 2025
DNA damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status
So Hyeon Kim, Yoonjung Park, Ahrum Min, et al.
JHEP Reports : Innovation in Hepatology
|
April 15, 2024
A phase Ib/II trial of capmatinib plus spartalizumab <i>vs.</i> spartalizumab alone in patients with pretreated hepatocellular carcinoma
Armando Santoro, Eric Assenat, Thomas Yau, et al.
Cancer Research and Treatment
|
April 30, 2025
Safety and Effectiveness of Eribulin in Patients with Advanced or Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes in Real-World Clinical Practice: A 6-Year Post-Marketing Surveillance Study in South Korea
Yee Soo Chae, Kyung A Kwon, Moon Hee Lee, et al.
Cancer Letters
|
January 24, 2012
Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer
Young-Kwang Yoon, Seock-Ah Im, Ahrum Min, et al.
Page
of 25
Search research articles
Search
Showing results (121-130 of 248) with videos related to
Sort By:
Page
of 25
Psychiatry Investigation
|
November 29, 2022
The Effect of Temperament on the Association Between Pre-treatment Anxiety and Chemotherapy-Related Symptoms in Patients With Breast Cancer
Jung-In Choi, Sanghyup Jung, Gyu Han Oh, et al.
Frontiers in Immunology
|
December 5, 2022
Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer
Jinyong Kim, Jiyun Jeong, Chan Mi Lee, et al.
Cancers
|
February 8, 2020
TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy
Jin Won Kim, Ahrum Min, Seock-Ah Im, et al.
BMC Cancer
|
July 9, 2016
Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer
Eun-Shin Lee, Wonshik Han, Min Kyoon Kim, et al.
Gut and Liver
|
May 19, 2010
Acute pancreatitis complicating spontaneous acute exacerbation of chronic hepatitis B virus infection: case report and review of the literature
Kyo-Sang Yoo, Kyung-Hun Lee, Kyung Rim Huh, et al.
Breast (Edinburgh, Scotland)
|
March 24, 2026
Impact of trastuzumab deruxtecan (T-DXd) and brain stereotactic radiosurgery on intracranial control and radionecrosis risk in HER2-positive or -low breast cancer brain metastases
Seok-Joo Chun, Kyubo Kim, Won Ick Chang, et al.
Cancer Research and Treatment
|
August 8, 2025
DNA damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status
So Hyeon Kim, Yoonjung Park, Ahrum Min, et al.
JHEP Reports : Innovation in Hepatology
|
April 15, 2024
A phase Ib/II trial of capmatinib plus spartalizumab <i>vs.</i> spartalizumab alone in patients with pretreated hepatocellular carcinoma
Armando Santoro, Eric Assenat, Thomas Yau, et al.
Cancer Research and Treatment
|
April 30, 2025
Safety and Effectiveness of Eribulin in Patients with Advanced or Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes in Real-World Clinical Practice: A 6-Year Post-Marketing Surveillance Study in South Korea
Yee Soo Chae, Kyung A Kwon, Moon Hee Lee, et al.
Cancer Letters
|
January 24, 2012
Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer
Young-Kwang Yoon, Seock-Ah Im, Ahrum Min, et al.
Page
of 25